1. Introduction {#sec1-molecules-24-04063}
===============

*Aesculus chinensis* Bge. var. *chekiangensis* (Hu et Fang) Fang belonging to the *Hippocastanaceae* family is a species endemic to China. Its dried seeds together with *Aesculus chinensis* Bge. and *Aesculus wilsonii* Rehd have been used in traditional Chinese medicine for treating chest and abdomen pain, dysentery and ague \[[@B1-molecules-24-04063],[@B2-molecules-24-04063]\]. Recently, many studies have demonstrated that *Aesculus chinensis* have beneficial effects involving their antitumor, cardio-protective, anti-inflammatory, and neuroprotective activities \[[@B3-molecules-24-04063],[@B4-molecules-24-04063]\]. Previous investigation of its chemical constituents resulted in various types of compounds, such as triterpenoids \[[@B5-molecules-24-04063],[@B6-molecules-24-04063],[@B7-molecules-24-04063]\], flavonoids \[[@B8-molecules-24-04063],[@B9-molecules-24-04063]\], coumarins \[[@B10-molecules-24-04063]\] and steroids. So far, most studies have been focused on components of less polarity fractions and little has been known about polar fractions consists. As an extension study on biologically active compounds from polar portion, six new indole glycosides (**1**--**6**) and six known analogs (**7**--**12**) were obtained ([Figure 1](#molecules-24-04063-f001){ref-type="fig"}) and their neuroprotective activities and cytotoxic activities were also evaluated.

2. Results {#sec2-molecules-24-04063}
==========

Compound **1** was isolated as a yellow, amorphous powder (MeOH). The UV spectrum showed absorption at 290 nm, and its pseudomolecular ion \[M+H\]^+^ at *m/z* 470.1655, indicating the presence of odd number of nitrogen atom in compound **1**. The HRMS analysis (*m/z* 470.1655 \[M + H\]^+^) and the NMR data ([Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}) indicated the molecular formula C~21~H~27~NO~11~.

The ^13^C-NMR spectrum exhibited resonances of 21 carbon signals composed of nine unsaturated carbons (δ~C~ 176.0, 138.2, 129.8, 126.4, 122.9, 120.9, 119.8, 111.7, 109.8), eleven sugar carbons (δ~C~ 105.0, 86.1, 81.1, 79.0, 77.7, 77.4, 75.8, 70.9, 70.8, 69.4, 62.0) and one additional aliphatic carbons (*δ*~C~ 31.9). The ^1^H-NMR spectrum displayed a spin coupling system of four aromatic protons \[δ~H~ 7.53 (1H, d, *J* = 7.8 Hz), 7.48 (1H, d, *J* = 8.3 Hz), 7.16 (1H, ddd, *J* = 8.2, 7.0, 1.2 Hz), 7.08 (1H, ddd, *J* = 7.5, 7.0, 0.9 Hz)\] indicating an ortho-substituted aromatic ring; an additional aromatic proton signal at δ~H~ 7.41 (1H, s), indicative of a 3-substituted indole moiety, an isolated methylene protons at *δ*~H~ 3.72 (2H, s) and two anomeric protons at *δ*~H~ 5.45 (1H, d, *J* = 9.0 Hz) and 4.35 (1H, d, *J* = 7.8 Hz).

All of the protons and carbons were unambiguously assigned by HSQC experiment.

The HMBC spectrum correlations between H-4 (*δ*~H~ 7.53, 1H, d, *J* = 7.8 Hz) and C-3 (*δ*~C~ 109.8), C-6 (δ~C~ 122.9), C-7a (δ~C~ 138.2); between H-5 (δ~H~ 7.08, 1H, ddd, *J* = 7.5, 7.0, 0.9 Hz) and C-7 (δ~C~ 111.7), C-3a (δ~C~ 129.8); between H-6 (δ~H~ 7.16, 1H, ddd, *J* = 8.2, 7.0, 1.2 Hz) and C-4 (δ~C~ 119.8), C-7a (δ~C~ 138.2) and between H-7 (δ~H~ 7.48, 1H, d, *J* = 8.3 Hz) and C-5 (δ~C~ 120.9), C-3a (δ~C~ 129.8) further confirm the existence of the ortho-substituted aromatic ring in compound **1**. The substituent at C(3) was deduced to be a CH~2~COOH group, supported by the HMBC correlations between H-2 (δ~H~ 7.41, 1H, s) and C-3a (*δ*~C~ 129.8), C-7a (δ~C~ 138.2), C-8 (δ~C~ 31.9) and between H-8 (δ~H~ 3.72) and C-2 (δ~C~ 126.4), C-3 (δ~C~ 109.8), C-3a (δ~C~ 129.8), C9 (δ~C~ 176.0). Thus, the aglycone of compound **1** was established as indole-3-acetic acid.

The two anomeric protons at *δ* 5.45 (1H, d, *J* = 9.0 Hz), 4.35 (1H, d, *J* = 7.8 Hz) correlated with carbons at *δ* 86.1 and 105.0 in HSQC spectrum, respectively, indicated disaccharide residues. Acid hydrolysis of **1** with 2M HCl produced [d]{.smallcaps}-glucose and [d]{.smallcaps}-xylose, which was identified with HPLC analysis by comparing with authentic sugar samples after derivatization \[[@B11-molecules-24-04063]\]. The *β*-configuration of the glycosidic linkages were deduced from the large coupling constants. In addition, the HMBC correlations of H-1′ (δ 5.45) with C-2, C-7a and H-1″ (δ 4.35) with C-3′ revealed the sequence glc-(1→3)-xyl to be linked at nitrogen of aglycone portion ([Figure 2](#molecules-24-04063-f002){ref-type="fig"}). Based on the above analyses, the structure of **1** was identified as *N*-\[*β*-[d]{.smallcaps}-glucopyranosyl(1→3)\]*-β*-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic acid.

Compound **2** was obtained as a yellow amorphous powder with the elemental formula C~22~H~29~NO~11~ (HR-ESI-MS *m/z*: 484.1811 \[M + H\]^+^; calculated for C~22~H~30~NO~11~, 484.1819). Acid hydrolysis of **2** yielded the same sugar units as **1**. Its NMR spectra were closely similar to those of **1** with the only difference of an extra methoxy signals (*δ*~H~ 3.71 and *δ*~C~ 52.5). The HMBC cross-peaks of H-10 (δ~H~ 3.71) with C-9 (δ~C~ 174.4) implied the -COOH in **1** was replaced by -COOCH~3~ in **2**, which was further confirmed by their formulas. Thus, compound **2** was assigned as *N*-\[*β*-[d]{.smallcaps}-glucopyranosyl(1→3)\]*-β*-[d]{.smallcaps}- xylopyranosyl-indole-3-methyl acetate.

Compound **3**, a yellow, amorphous powder, was assigned the molecular formula C~20~H~25~NO~10~ (HRESIMS *m/z* 440.1549 \[M + H\]^+^; calculated for C~20~H~26~NO~10~, 440.1557). The sugar chain of **3** was the same as that of **2** by comparing their ^1^H and ^13^C-NMR data ([Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}) and analysis of the hydrolysis result. The similar NMR spectra of **3** to those of **1** and **2** indicated that compound **3** is a structural analogue of these compounds. The ^1^H-NMR spectra showed proton resonances corresponding to a 3-substituted indole group \[δ~H~ 8.18 (1H, d, *J* = 7.7 Hz), 7.62 (1H, d, *J* = 8.1 Hz), 7.31 (1H, ddd, *J* = 8.1, 7.3, 1.1 Hz), 7.26 (1H, ddd, *J* = 7.7, 7.3, 0.9 Hz), 8.37 (1H, s)\]. The substituent at C-3 was deduced as a formyl moiety, established by HSQC correlations between H-8 (*δ*~H~ 3.71) and C-8 (δ~C~ 187.7) together with the HMBC correlations between H-8 (δ~H~ 3.71) and C-3 (δ~C~ 119.7) as well as C-3a (δ~C~ 126.4). Hence, **3** was defined as *N*-\[*β*-[d]{.smallcaps}-glucopyranosyl(1→3)\]*-β*-[d]{.smallcaps}-xylopyranosyl-indole-3-carbaldehyde.

Compound **4** was assigned the molecular formula of C~27~H~37~NO~16~ from HRESIMS (*m*/*z* 632.2150 \[M + H\]^+^*,* calculated for 632.2191) and its NMR data. The MS and NMR spectra were closely parallel to those of **1**, revealing the same aglycone and sugar residues with the difference of an additional hexose unit (162 Da) in compound **4**. This conclusion was further ensured by hydrolysis, conversion to chiral diastereomers and HPLC analysis. The HMBC correlations from H-1′ (δ 5.46) to C-2 (δ 126.4), C-7a (δ138.2), from H-1″ (δ 4.37) to C-3′ (δ 80.5) and from H-1‴ (δ 4.43) to C-4′ (δ 77.6) confirmed the linkage of the trisaccharide moiety in **4**. Consequently, it was assigned as *N*-\[*β*-[d]{.smallcaps}-glucopyranosyl(1→3)-\[*β*-[d]{.smallcaps}-glucopyranosyl (1→4)\]*-β*-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic acid.

For compound **5**, isolated as a yellowish powder, established the molecular formula was C~15~H~17~NO~6~ by HRESIMS (*m*/*z* 308.1136 \[M + H\]^+^; calculated for C~15~H~18~NO~6~, 308.1134). Acid hydrolysis of **5** yielded [d]{.smallcaps}-xylose, which was identified using the same method as **1**--**4**. Analysis of the ^1^H- and ^13^C-NMR spectroscopic data ([Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}) of **5** displayed a close structural resemblance to **1**, except for the absence of a [d]{.smallcaps}-glucose. This deduction was supported by the key HMBC correlations from H-1′ (δ 5.31) to C-2 (*δ* 125.0), C-7a (δ 138.3) and from H-8 (δ 3.66) to C-2 (δ 125.0), C-3 (δ112.2), C3a (δ130.2), C9 (δ180.1). Accordingly, **5** was unambiguously established as *N-β*-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic acid.

Compound **6** had a molecular formula of C~22~H~29~NO~12~, which was established from the \[M+H\]^+^ ion at *m*/*z* 500.1762 (calculated for 500.1768) in the positive HR-ESI-MS, 30 mass units more than that of **1**. Comparison of the NMR data of **6** with those of **1** showed that both isolates are closely related, but only differed at the disaccharide group. Acid hydrolysis suggested that only [d]{.smallcaps}-glucose existed in **6**. As observed in the HMBC spectrum, the long-range correlations of H-1′ (δ 5.56) with C-2 (δ 126.4), C-7a (δ138.4) and H-1″ (δ 4.38) with C-2′ (δ 81.2) provided definitive evidences that the linkage glc-(1→2)-glc was bound to nitrogen of aglycone portion. Therefore, compound **6** was defined as *N*-\[*β*-[d]{.smallcaps}-glucopyranosyl (1→2)\]*-β*-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic acid.

The known indoles were identified as *N*-*β*-[d]{.smallcaps}-glucopyranosyl-indole-3-acetic acid (**7**) \[[@B12-molecules-24-04063]\], *N*-*β*-[d]{.smallcaps}-glucopyranosyl-indole-3-methyl acetate (**8**) \[[@B13-molecules-24-04063]\], methyl dioxindole-3-acetate (**9**) \[[@B14-molecules-24-04063]\], indole-3-acetic acid (**10**) \[[@B15-molecules-24-04063]\], indole-3-methyl acetate (**11**) \[[@B15-molecules-24-04063]\], indole-3-carboxylic acid methyl ester (**12**) \[[@B16-molecules-24-04063]\] by NMR analysis and comparison with literature data.

It has been reported that *Aesculus chinensis* showed neuroprotective activities \[[@B3-molecules-24-04063]\]. In the present study, the isolated compounds **1**−**10** were also evaluated for their neuroprotective effects against CoCl~2~-induced PC12 cell damage. As shown in [Figure S43](#app1-molecules-24-04063){ref-type="app"}, all substances showed no obvious cytotoxic effects on PC12 cells at a dose of 10 μM. Then, 10 μM samples were bioassayed for neuroprotective activities against CoCl~2~-induced toxicity in PC12 cells with Trolox (10 μM) as the positive control. According to [Figure 3](#molecules-24-04063-f003){ref-type="fig"}, compared with the Trolox, compounds **1**--**5** and **9--10** show similar effect on increasing the cell viabilities in CoCl~2~-treated PC12 cells, indicating that compounds **1**--**5** and **9**--**10** exhibited statistically significant neuroprotective activities.

The cytotoxic activities against three human cancer cell lines (Hep G2, HCT-116, and MGC-803) of compounds **1**--**10** were assayed using the MTT method, with 5-fluorouracil (5-FU) as the positive control. None of these compounds displayed cytotoxic activity (IC~50~ \> 50 μM) ([Table S1](#app1-molecules-24-04063){ref-type="app"}).

3. Materials and Methods {#sec3-molecules-24-04063}
========================

3.1. General Experimental Procedures {#sec3dot1-molecules-24-04063}
------------------------------------

Optical rotations were recorded on a Rudolph (Hackettstown, NJ, USA) Autopol V automatic polarimeter. The UV spectra were acquired on a UNICO 2102PCS spectrophotometer (Dayton, NJ, USA). The IR spectra were obtained in a KBr-disc (cm^−1^) on a Brucker Tensor II spectrometer (Billerica, MA, USA). NMR spectra were carried out on a Bruker (Billerica, MA, USA) AM-600 spectrometer at 25 °C referencing to the residuals of CD~3~OD. High-Resolution-ESI-MS (HR-ESI-MS) was performed on a Waters (Milford, MA, USA) Xevo G2-S UPLC-Q/TOF equipped with an ACQUITY UPLC BEH C18 (2.1 × 50 mm, Waters 1.7 μm, Milford, MA, USA). Analytical HPLC were performed on a Waters e2695 system equipped with a 2998 PDA detector (Waters, Milford, MA, USA) using a YMC-Pack-ODS-A column (250 × 4.6 mm, 5 μm, YMC, Tokyo, Japan). Semi-preparative HPLC was performed using a Shimadzu LC-6AD Series instrument equipped with a YMC Packed C~18~ column (250 × 10.0 mm, 5 μm, YMC, Tokyo, Japan) and detected with a DAD detector (Shimadzu, Tokyo, Japan) set at 205 and 230 nm. Column chromatography (CC) was done with Sephadex LH-20 (GE Healthcare Co. Ltd., Marlborough, MA, USA), ODS RP-C~18~ (40--75 μm Merck, Darmstadt, Germany), macroporous resin D101 (Chemical Plant of Nankai University, Tianjin, China), and silica gel (200--400 mesh, Qingdao Haiyang Chemical, Qingdao, China). All reagents used were of analytical grade (Concord Technology Co. Ltd., Tianjin, China).

3.2. Plant Material {#sec3dot2-molecules-24-04063}
-------------------

Seeds of *Aesculus chinensis* Bge. var. *chekiangensis* (Hu et Fang) Fang were purchased from An guo (Hebei Province, China) in August 2015, and authenticated by professor Lijuan Zhang (Tianjin University of Traditional Chinese Medicine, Tianjin, China). A voucher specimen was deposited at the School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine.

3.3. Extraction and Isolation {#sec3dot3-molecules-24-04063}
-----------------------------

The dried seeds of *A. chinensis* Bge. (8.8 kg) were cut into small pieces and were extracted with 70% ethanol three times (3 h) under reflux. After removal of the solvent under reduced pressure, a dark residue (2100 g) was afforded. The residue was suspended in H~2~O and subjected to D101 resin and then sequentially eluted with H~2~O, a gradient of EtOH in water to yield the corresponding fractions. The 20% EtOH−H~2~O part was further fractionated with a silica gel column, eluting with a gradient of 0--100% CH~2~Cl~2~/CH~3~OH to yield 4 fractions (A--D).

Fraction A (8.0 g) was applied to an RP C~18~ CC (MeOH−H~2~O, from 0:100 to 50:50) to give four subfractions (A1−A4). Subfraction A2 was purified by an RP-HPLC (MeCN−H~2~O, 8:92, 3.0 mL/min) to obtain compounds **9** (6.7 mg, *t*~R~ 11.2 min) and **12** (5.4 mg, *t*~R~ 14.7 min). Further purification of subfraction A3 using preparative RP-HPLC (MeCN−H~2~O, 8:92, 3.0 mL/min) yielded compounds **10** (4.8 mg, *t*~R~ 16.5 min) and **11** (2.3 mg, *t*~R~ 17.8 min).

Fraction C (22.0 g) was applied to an ODS MPLC column eluting with gradient MeOH−H~2~O from 10:90 to 100: 0 to afford five major subfractions (C1--C5). Compound **4** (9.2 mg, *t*~R~ 31.5 min) was purified by preparative HPLC with 10% MeCN/H~2~O from subfraction C1. Compounds **1** (7.1 mg, *t*~R~ 8.9 min), **2** (13.5 mg, *t*~R~ 9.7 min), **3** (11.0 mg, *t*~R~ 13.4 min) and **6** (9.6 mg, *t*~R~ 16.5 min) were obtained from Fr. C2 using Sephadex LH-20 column and further purified by RP-HPLC (MeCN−H~2~O 15: 85, *v*/*v*, 3.0 mL/min). Subfraction C3 was purified by preparative HPLC to afford compounds **7** (7.0 mg, *t*~R~ 16.5 min) and **8** (9.1 mg, *t*~R~ 18.2 min) using 15% MeCN/H~2~O. Subfraction C4 was chromatographed on a Sephadex LH-20 column and then purified through preparative HPLC with 15% MeCN/H~2~O to yield compound **5** (9.8 mg, *t*~R~ 20.3 min).

### 3.3.1. *N*-\[β-[d]{.smallcaps}-glucopyranosyl(1→3)\]-β-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic Acid (**1**) {#sec3dot3dot1-molecules-24-04063}

Yellow amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ -- 3.2 (*c* 0.1, MeOH); ^1^H-NMR and ^13^C-NMR: [Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}; HR-ESI-MS: *m/z* 470.1655 \[M + H\]^+^ (calculated for C~21~H~28~NO~11~, 470.1662).

### 3.3.2. *N*-\[β-[d]{.smallcaps}-glucopyranosyl(1→3)\]-β-[d]{.smallcaps}-xylopyranosyl-indole-3-methyl Acetate (**2**) {#sec3dot3dot2-molecules-24-04063}

Yellow amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ -- 2.0 (*c* 0.10, MeOH); ^1^H-NMR and ^13^C-NMR: [Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}; HR-ESI-MS: *m/z* 484.1811 \[M + H\]^+^ (calculated for C~22~H~30~NO~11~, 484.1819).

### 3.3.3. *N*-\[β-[d]{.smallcaps}-glucopyranosyl(1→3)\]-β-[d]{.smallcaps}-xylopyranosyl-indole-3-carbaldehyde (**3**) {#sec3dot3dot3-molecules-24-04063}

Yellow amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ -- 2.2 (*c* 0.11, MeOH); ^1^H-NMR and ^13^C-NMR: [Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}; HR-ESI-MS: *m/z* 440.1549 \[M + H\]^+^ (calculated for C~20~H~26~NO~10~, 440.1557).

### 3.3.4. *N*-\[β-[d]{.smallcaps}-glucopyranosyl(1→3)-\[β-[d]{.smallcaps}-glucopyranosyl(1-4)\]-β-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic Acid (**4**) {#sec3dot3dot4-molecules-24-04063}

Yellow amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ -- 6.3 (*c* 0.10, MeOH); ^1^H-NMR and ^13^C-NMR: [Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}; HR-ESI-MS: *m/z* 632.2150 \[M + H\]^+^ (calculated for C~27~H~38~NO~16~, 632.2191).

### 3.3.5. *N*-β-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic Acid (**5**) {#sec3dot3dot5-molecules-24-04063}

Yellowish powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ -- 2.0 (*c* 0.12, MeOH); ^1^H-NMR and ^13^C-NMR: [Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}; HR-ESI-MS: *m/z* 308.1136 \[M + H\]^+^ (calcd. for C~15~H~18~NO~6~, 308.1134).

### 3.3.6. *N*-\[β-[d]{.smallcaps}-glucopyranosyl(1→2)\]-β-[d]{.smallcaps}-xylopyranosyl-indole-3-acetic Acid (***6***) {#sec3dot3dot6-molecules-24-04063}

Yellowish powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ -- 4.8 (*c* 0.09, MeOH); ^1^H-NMR and ^13^C-NMR: [Table 1](#molecules-24-04063-t001){ref-type="table"} and [Table 2](#molecules-24-04063-t002){ref-type="table"}; HR-ESI-MS: *m/z* 500.1762 \[M + H\]^+^ (calculated for C~22~H~30~NO~12~, 500.1768).

### 3.3.7. Hydrolysis and Determination of Absolute Configuration of Sugars {#sec3dot3dot7-molecules-24-04063}

A solution of **1**--**6** (1.0 mg, respectively) dissolved in 2 M HCl (4.0 mL) was heated at 90 °C for 2 h. The reaction mixture was extracted two times with EtOAc (4 mL), and the aqueous layer was evaporated to dryness under N~2~ atmosphere. Then [l]{.smallcaps}-cysteine methyl ester (1.0 mg) was added to the residues dissolved in pyridine (1.0 mL) and heated at 60 °C. One hour later, *o*-tolyisothiocyanate (1.0 mL) was added and heated for another hour. Then each reaction mixture was analyzed by the Waters e2695 HPLC system (YMC- Pack-ODS-A column, 1.0 mL/min, 250 nm) eluting with A (0.1% formic acid): B (acetonitrile) = 80: 20 (*v*/*v*). By comparison of the retention times with the standards, the absolute configuration of sugars in **1**--**6** was established \[[@B11-molecules-24-04063],[@B17-molecules-24-04063]\].

3.4. Neuroprotective Effect Assay {#sec3dot4-molecules-24-04063}
---------------------------------

The neuroprotective effects of compounds **1**--**10** was evaluated on CoCl~2~ damaged PC12 cells model \[[@B18-molecules-24-04063],[@B19-molecules-24-04063]\]. Rat pheochromocytoma cell line (PC12) were cultured in RPMI-1640 medium with 10% (*v*/*v*) inactivated fetal bovine serum and 100 U/mL penicillin/streptomycin. The cells were grown and treated at 37 °C in 5% CO~2~ and 95% humidified air incubator. Cells were placed into a 96-well plate at a density of 2 × 10^4^ cells/well and kept there for 24 h for the adherence of the cells. Cells were treated with the compounds at concentrations of 10 μM for 2 h. After incubation, 1 mM CoCl~2~ was added and incubated for 24 h. After a 24 h treatment, the supernatant was changed with MTT solution (5 mg/mL). After incubation at 37 °C for 4 h, cells were finally lysed with 150 μL of DMSO. The absorbance was measured at 490 nm with a microplate reader. The cell viability was indicated as a percentage of the live control cells. The results were expressed as means ± SD of the indicated numbers from three independent experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) and Student's Dunnett test using the SPSS statistical software (version 19 for Windows, IBM Corp., Armonk, NY, USA). P values below 0.05 were considered statistically significant.

3.5. Cytotoxicity Assay {#sec3dot5-molecules-24-04063}
-----------------------

The human cancer cell lines, HepG2, HCT-116, and MGC-803 were purchased from ATCC. The in vitro cytotoxicity of compounds **1**--**10** was tested by MTT assay \[[@B20-molecules-24-04063],[@B21-molecules-24-04063]\] with 5-fluorouracil as the positive control. The tested cell lines were cultured in 96-well plates at a density of 1 × 10^4^ cells/well and incubated for 24 h. Subsequently, cells were treated with compounds **1**--**10** at a dosage of 3.125--50 μM, respectively. After 24 h, the supernatant was changed with MTT solution (5 mg/mL) and incubated for another 4 h. Then cells were finally lysed with 150 μL of DMSO and the absorbance was measured at 490 nm with a microplate reader. The cell viability was indicated as a percentage of the live control cells.

4. Conclusions {#sec4-molecules-24-04063}
==============

In summary, this is the first study of the water-soluble portion of *Aesculus chinensis* Bge. var. *chekiangensis* (Hu et Fang) Fang, six new indole glycosides (**1**--**6**) along with six known analogs were isolated and characterized. What is more, this is the first report of *N*-glucosylated indoles from *Aesculus* genus, which largely enriched its chemical diversity. In addition, the neuroprotective activities of the *N*-glucosylated indoles were evaluated for the first time and compounds **1**--**5**, **9**--**10** exhibited statistically significant neuroprotective activities.

**Sample Availability:** Samples of the compounds are not available from the authors.

The following are available online: antitumor activities (IC~50~ μM, *n* = 3) of compounds **1**--**10** and 5-Fu (Table S1), UV, IR, HR-ESI-MS, 1D- and 2D-NMR spectra of compounds **1**--**6** (Figures S1--S42), cytotoxic activities of compounds **1**--**10** on PC12 cells at 10 μM (Figure S43).

###### 

Click here for additional data file.
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###### 

^1^H-NMR spectroscopic data (*δ*) for compounds **1**--**6**^a^ (δ in ppm, *J* in Hz).

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  NO.   1                                        2                                        3                                        4                                        5                                         6
  ----- ---------------------------------------- ---------------------------------------- ---------------------------------------- ---------------------------------------- ----------------------------------------- ----------------------------------------
  2     7.41 (1H, s)                             7.44 (1H, s)                             8.37 (1H, s)                             7.41 (1H, s)                             7.25 (1H, s)                              7.47 (1H, s)

  4     7.53 (1H, d, *J* = 7.8 Hz)               7.54 (1H, d, *J* = 7.8 Hz)               8.18 (1H, d, *J* = 7.7 Hz)               7.53 (1H, d, *J* = 7.8 Hz)               7.54 (1H, d, *J* = 7.9 Hz)                7.54 (1H, d, *J* = 7.9 Hz)

  5     7.08 (1H, ddd, *J* = 7.5, 7.0, 0.9 Hz)   7.11 (1H, ddd, *J* = 7.5, 7.0, 0.9 Hz)   7.26 (1H, ddd, *J* = 7.7, 7.3, 0.9 Hz)   7.08 (1H, ddd, *J* = 7.5, 7.0, 1.2 Hz)   7.06 (1H, ddd, *J* = 7.9, 7.0, 0.9 Hz)    7.08 (1H, ddd, *J* = 7.5, 7.0, 1.2 Hz)

  6     7.16 (1H, ddd, *J* = 8.2, 7.0, 1.2 Hz)   7.19 (1H, ddd, *J* = 8.2, 7.0, 1.1 Hz)   7.31 (1H, ddd, *J* = 8.1, 7.3, 1.1 Hz)   7.16 (1H, ddd, *J* = 8.2, 7.0, 1.2 Hz)   7.15 (1H, ddd, *J* = 8.2, 7.0, 1.1 Hz)    7.17 (1H, ddd, *J* = 8.2, 7.0, 1.2 Hz)

  7     7.48 (1H, d, *J* = 8.3 Hz)               7.51 (1H, d, *J* = 8.3 Hz)               7.62 (1H, d, *J* = 8.1 Hz)               7.48 (1H, d, *J* = 8.2 Hz)               7.48 (1H, d, *J* = 8.3 Hz)                7.51 (1H, d, *J* = 8.3 Hz)

  8     3.72 (2H, s)                             3.79 (2H, s)                             9.91 (1H, s)                             3.71 (2H, s)                             3.66 (2H, s)                              3.72 (2H, s)

  10                                             3.71 (3H, s)                                                                                                                                                         

        Xyl-*p*                                  Xyl-*p*                                  Xyl-*p*                                  Xyl-*p*                                  Xyl-*p*                                   Glc-*p*

  1′    5.45 (1H, d, *J* = 9.0 Hz)               5.48 (1H, d, *J* = 9.0 Hz)               5.58 (1H, d, *J* = 9.0 Hz)               5.46 (1H, d, *J* = 9.0 Hz)               5.31 (1H, d, *J* = 9.0 Hz)                5.56 (1H, d, *J* = 9.0 Hz)

  2′    3.75 (1H, m)                             3.78 (1H, m)                             3.80 (1H, m)                             3.93 (1H, d, *J* = 8.8 Hz)               3.89 (1H, t, *J* = 9.0 Hz)                4.21 (1H, t, *J* = 9.0 Hz)

  3′    4.19 (1H, t, *J* = 8.8 Hz)               4.21 (1H, t, *J* = 8.7 Hz)               4.26 (1H, t, *J* = 8.6 Hz)               4.26 (1H, t, *J* = 8.7 Hz)               3.54 (1H, t, *J* = 9.0 Hz)                3.82 (1H, t, *J* = 8.8 Hz)

  4′    3.74 (1H, m)                             3.76 (1H, m)                             3.78 (1H, m)                             3.96 (1H, m)                             3.69 (1H, ddd, *J* = 10.6, 9.0, 5.5 Hz)   3.54 (1H, m)

  5′    3.48 (1H, m)\                            3.50 (1H, m)\                            3.56 (1H, t, *J* = 10.5 Hz)\             3.56 (1H, d, *J* = 10.8 Hz)\             3.48 (1H, t, *J* = 11.0 Hz)\              3.56 (1H, m)
        3.97 (1H, m)                             3.99 (1H, dd, *J* = 11.4, 4.7 Hz)        4.06 (1H, dd, *J* = 11.3, 4.7 Hz)        4.15 (1H, dd, *J* = 11.6, 5.1 Hz)        3.97 (1H, dd, *J* = 11.3, 5.5 Hz)         

  6′                                                                                                                                                                                                                  3.70 (1H, m)\
                                                                                                                                                                                                                      3.86 (1H, dd, *J* = 12.2, 2.0 Hz)

        Glc-*p*                                  Glc-*p*                                  Glc-*p*                                  Glc-*p*                                                                            Glc-*p*

  1″    4.35 (1H, d, *J* = 7.8 Hz)               4.38 (1H, d, *J* = 7.8 Hz)               4.48 (1H, d, *J* = 7.8 Hz)               4.37 (1H, d, *J* = 7.8 Hz)                                                         4.38 (1H, d, *J* = 7.8 Hz)

  2″    2.95 (1H, dd, *J* = 9.3, 7.8 Hz)         2.98 (1H, dd, *J* = 9.3, 7.8 Hz)         2.89 (1H, m)                             2.95 (1H, dd, *J* = 9.3, 7.8 Hz)                                                   2.96 (1H, dd, *J* = 9.3, 7.8 Hz)

  3″    3.17 (1H, t, *J* = 9.1 Hz)               3.20 (1H, t, *J* = 8.5 Hz)               3.16 (1H, d, *J* = 8.9 Hz)               3.17 (1H, d, *J* = 9.1 Hz)                                                         3.20 (1H, t, *J* = 9.1 Hz)

  4″    3.05 (1H, t, *J* = 9.4 Hz)               3.06 (1H, t, *J* = 9.4 Hz)               2.92 (1H, m)                             3.04 (1H, t, *J* = 9.4 Hz)                                                         3.05 (1H, t, *J* = 9.4 Hz)

  5″    2.74 (1H, ddd, *J* = 9.8, 4.6, 2.5 Hz)   2.77 (1H, ddd, *J* = 9.7, 4.7, 2.6 Hz)   2.87 (1H, m)                             2.73 (1H, ddd, *J* = 9.9, 4.6, 2.5 Hz)                                             2.77 (1H, ddd, *J* = 9.8, 4.5, 2.5 Hz)

  6″    3.10 (1H, dd, *J* = 11.8, 2.5 Hz)\       3.13 (1H, dd, *J* = 11.7, 2.6 Hz)\       3.16 (1H, d, *J* = 8.9 Hz)\              3.10 (1H, dd, *J* = 11.8, 2.5 Hz)\                                                 3.14 (1H, dd, *J* = 11.8, 2.5 Hz)\
        3.21 (1H, dd, *J* = 11.7, 4.6 Hz)        3.23 (1H, dd, *J* = 11.1, 4.1 Hz)        3.35 (1H, dd, *J* = 11.6, 2.5 Hz)        3.21 (1H, dd, *J* = 12.2, 4.8 Hz)                                                  3.23 (1H, dd, *J* = 11.8, 4.6 Hz)

                                                                                                                                   Glc-*p*                                                                            

  1‴                                                                                                                               4.43 (1H, d, *J* = 7.8 Hz)                                                         

  2‴                                                                                                                               3.26 (1H, dd, *J* = 9.2, 7.8 Hz)                                                   

  3‴                                                                                                                               3.35 (1H, m)                                                                       

  4‴                                                                                                                               3.29 (1H, m)                                                                       

  5‴                                                                                                                               3.33 (1H, m)                                                                       

  6‴                                                                                                                               3.67 (1H, dd, *J* = 12.0, 5.9 Hz)\                                                 
                                                                                                                                   3.89 (1H, dd, *J* = 12.4, 2.5 Hz)                                                  
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ NMR data (δ) were measured at 600 MHz in CD~3~OD for **1**--**6**.

molecules-24-04063-t002_Table 2

###### 

^13^C-NMR spectroscopic data (*δ*) for compounds **1**--**6**^a^ (*δ* in ppm).

  NO.   1         2         3         4         5         6
  ----- --------- --------- --------- --------- --------- ---------
  2     126.4     126.5     141.4     126.4     125.0     126.4
  3     109.8     109.4     119.7     109.9     112.2     109.7
  3a    129.8     129.6     126.4     129.8     130.2     129.7
  4     119.8     119.8     122.5     119.9     120.0     119.8
  5     120.9     120.9     124.1     120.9     120.7     120.9
  6     122.9     122.9     125.0     122.9     122.9     122.9
  7     111.7     111.7     112.8     111.7     111.3     111.7
  7a    138.2     138.2     139.0     138.2     138.3     138.4
  8     31.9      31.7      187.7     31.9      33.8      31.9
  9     176.0     174.4               176.0     180.1     175.9
  10              52.5                                    
        Xyl-*p*   Xyl-*p*   Xyl-*p*   Xyl-*p*   Xyl-*p*   Glc-*p*
  1′    86.1      86.1      86.5      86.0      87.5      85.2
  2′    79.0      79.0      78.9      77.3      73.7      81.2
  3′    81.1      81.0      79.8      80.5      78.8      78.9
  4′    70.9      70.9      70.7      77.6      71.1      71.2
  5′    69.4      69.4      69.7      67.1      69.5      80.5
  6′                                                      62.6
        Glc-*p*   Glc-*p*   Glc-*p*   Glc-*p*             Glc-*p*
  1″    105.0     105.0     104.5     104.9               104.9
  2″    75.8      75.7      75.5      75.7                75.7
  3″    77.7      77.7      77.7      77.8                77.7
  4″    70.8      70.9      71.1      70.8                70.8
  5″    77.4      77.4      77.6      77.2                77.4
  6″    62.0      62.1      62.3      62.0                62.1
                                      Glc-*p*             
  1‴                                  103.4               
  2‴                                  74.6                
  3‴                                  77.9                
  4‴                                  71.5                
  5‴                                  78.1                
  6‴                                  62.6                

^a^ NMR data (*δ*) were measured at 150 MHz in CD~3~OD for **1**--**6**.
